Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs PNC Financial Services Group Inc. (The) Common Stock (PNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs PNC Financial Services Group Inc. (The) Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.53 (market cap $12.58B), while PNC Financial Services Group Inc. (The) Common Stock trades at $219.52 (market cap $87.64B). The key difference: PNC Financial Services Group Inc. (The) Common Stock is far larger — about 7× Halozyme Therapeutics Inc. Common Stock's market cap, and PNC Financial Services Group Inc. (The) Common Stock pays a 3.64% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| HALO | PNC | |
|---|---|---|
Market Cap | $12.58B | $87.64B |
Volume | 2,179,278 | 1,687,662 |
Sector | Health | Financials |
52-Week High | $115.22 | $256.97 |
52-Week Low | $61.63 | $178.37 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $14.49B | $144.63B |
Dividend Yield | — | 3.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About PNC Financial Services Group Inc. (The) Common Stock
PNC Financial Services Group is a financial services holding company. Its businesses include retail banking, corporate and institutional banking, and asset management.
Read more on PNC →
